Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1130D

PE Anti-Human HLA-A,B,C Antibody[W6/32]

PE Anti-Human HLA-A,B,C Antibody[W6/32]

Regular price $220.00 USD
Regular price Sale price $220.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Concentration
Host

PE Anti-Human HLA-A,B,C Antibody[W6/32]

The PE Anti-Human HLA-A,B,C Antibody [W6/32] is a highly specific and reliable tool designed for the detection and analysis of human leukocyte antigen (HLA) molecules. This antibody, labeled with phycoerythrin (PE), offers exceptional sensitivity and precision in identifying HLA-A, HLA-B, and HLA-C antigens on the surface of human cells.

The W6/32 clone used in the production of this antibody has been extensively validated and proven to exhibit minimal cross-reactivity with other HLA class I molecules. This ensures accurate and unambiguous results, making it an indispensable tool for researchers and clinicians involved in HLA-related studies, such as transplantation, immunology, and disease association.

The PE Anti-Human HLA-A,B,C Antibody [W6/32] is manufactured using state-of-the-art techniques, guaranteeing high purity and batch-to-batch consistency. Its exceptional performance characteristics, including high signal-to-noise ratio and low background staining, enable precise and reproducible flow cytometric analysis.

This antibody is supplied in a convenient format, ready for immediate use in various applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its compatibility with multiple sample types, such as peripheral blood cells, lymphocytes, and cell lines, further enhances its versatility and utility.

In summary, the PE Anti-Human HLA-A,B,C Antibody [W6/32] is a superior reagent that offers exceptional specificity, sensitivity, and reliability in the detection and analysis of HLA-A, HLA-B, and HLA-C antigens. Its high-quality manufacturing and compatibility with various applications make it an invaluable tool for researchers and clinicians in the field of HLA-related studies.

View full details